Omaha, NE, June 09, 2023 –(PR.com)– Endolumik, an innovator in minimally-invasive surgical devices, today announced that its fluorescence guided Gastric Calibration Tube has begun commercial sales, starting with the prestigious Nebraska Medicine Bariatrics Center.

Endolumik’s novel surgical tool has been used extensively in clinical trials and recently received 510(k) authorization as the first device ever through the FDA’s Safer TEchnology Program, or STEP. According to the FDA, the STEP program is for devices that are “reasonably expected to significantly improve the safety of currently available treatments.” The NIR fluorescence of the Endolumik device is designed to help surgeons avoid adverse events that can be caused by poor visualization. This procedure with UNMC will mark the first introduction of the device for public use.

Dr. Corrigan McBride, DABOM, FACS, FASMBS, and the Chief of General Surgery, Minimally Invasive…